Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses

Table 6

The prognosis of the 14 patients who underwent TACE.

Classification	Patients number	Number of CR+PR+SD	Number of PD		P value	Number of deaths	Number of survival cases		P value
CTC+ group	9	2	7	1.998	0.266	6	3	0.933	0.580
CTC- group	5	3	2			2	3
Twist+ CTC group	8	1	7	4.381	0.091	6	2	2.431	0.277
Twist- CTC group	6	4	2			2	4

Note. 14 HCC patients underwent TACE. All patients were followed up for no less than 1 year. P values are from Fisher’s exact test.
CTCs: circulating tumor cells; HCC: hepatocellular carcinoma; TACE: transcatheter arterial chemoembolization; CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease.